Lucinactant(loo sin ak’ tant)
Surfaxin
UNKNOWN
Drug class
Lung surfactant
Therapeutic Actions
Nonpyrogenic pulmonary surfactant containing lipids and peptides that reduce surface tension and all expansion of the alveoli; replaces the surfactant missing from the lungs of preterm infants
Indications
Prevention of RDS in preterm infants at high risk for RDS
Contraindications and Cautions
None known.
Available Forms
Suspension—8.5 mL/vial
Dosages
Pediatric patients
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
